[Pediatric very early onset inflammatory bowel disease: Role of pathology]

Philippe Drabent1, Dominique Berrebi1

  • 1Service d'anatomie et cytologie pathologiques, hôpitaux universitaires Necker-Enfants malades et Robert Debré, AP-HP, université de Paris, 149, rue de Sèvres, 75015 Paris, France.

Annales De Pathologie
|March 2, 2023
PubMed

Insights

Very early onset inflammatory bowel diseases (VEO-IBD) in young children are often monogenic. This review details the clinical features, genes, and histology of monogenic VEO-IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Genetics
  • Immunology

Context:

  • Inflammatory bowel diseases (IBD) encompass Crohn's disease and ulcerative colitis, characterized by immune dysregulation in genetically susceptible individuals.
  • Very early onset inflammatory bowel diseases (VEO-IBD), affecting children under six, frequently present as monogenic disorders, accounting for over a third of cases.
  • Over 80 genes are implicated in VEO-IBD, yet detailed pathological descriptions remain limited.

Purpose:

  • To clarify the clinical manifestations of monogenic VEO-IBD.
  • To identify the primary causative genes associated with monogenic VEO-IBD.
  • To outline the diverse histological patterns observed in intestinal biopsies from VEO-IBD patients.

Summary:

  • Monogenic VEO-IBD presents distinct clinical features and is linked to over 80 genes.
  • Histological examination of intestinal biopsies reveals varied patterns in monogenic VEO-IBD.
  • Genetic analysis is crucial for diagnosing and understanding the pathogenesis of VEO-IBD.

Impact:

  • Provides a comprehensive overview of monogenic VEO-IBD for clinicians and researchers.
  • Highlights the importance of a multidisciplinary approach involving pediatric gastroenterologists, immunologists, geneticists, and pathologists.
  • Aids in the accurate diagnosis and tailored management of pediatric patients with VEO-IBD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
331
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
263
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
383
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
512
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
320
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169